Practical daily effectiveness and tolerance of Procoralan in chronic systolic heart failure in Germany.

Trial Profile

Practical daily effectiveness and tolerance of Procoralan in chronic systolic heart failure in Germany.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2015

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Chronic heart failure
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Acronyms INTENSIFY
  • Sponsors Servier
  • Most Recent Events

    • 31 Dec 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 22 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top